Global Oncology Drug Sales Growth Is Highest Among Top 10 Treatment Classes
This article was originally published in The Pink Sheet Daily
Executive Summary
Oncology, lipid lowering and respiratory drugs helped to fuel 7 percent sales growth in the global pharmaceutical market in 2006, IMS reports.
You may also be interested in...
Cancer Drugs Become Top Selling Therapeutic Category In The World
Lipid-lowering drugs remain top category in U.S., despite lower sales.
Cancer Drugs Become Top Selling Therapeutic Category In The World
Lipid-lowering drugs remain top category in U.S., despite lower sales.
Generic Drug Sales Grew 22 Percent In 2006 Driven By Unbranded Zocor, Plavix
Sales of Teva's simvastatin were $911 million, and sales of Apotex's clopidogrel were $902 million, according to IMS Health data.